Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Sep 01, 2023 10:17am
82 Views
Post# 35615789

Will the legalization of medical cannabis in France

Will the legalization of medical cannabis in France

Will the legalization of medical cannabis in France
be included in the PLFSS 2024? (Budget 2024)


If the prospect of the legalization of medical cannabis is awaited by French patients, the various currents of decision would thus go rather against a generalization of medical cannabis. We are just told that the Ministry of Health would like a generalization, the absence of which would be incomprehensible given the European panorama of medical cannabis with more than 20 countries having legalized one form or another of cannabis-based treatment. And from the German neighbor which, not content with being the first European country in terms of medical cannabis , is currently embarking on its first phase of legalization of cannabis for adults.

https://www.newsweed.fr/legalisation-cannabis-medical-france-plfss-2024/
<< Previous
Bullboard Posts
Next >>